The Path Forward: Vaccines with Johnson a Johnson CEO Alex Gorsky
Johnson a Johnson CEO Alex Gorsky joins The Post to discuss the company’s covid-19 vaccine, which is easier to use and store, requires only a single dose and was recently granted emergency use authorization in the U.S.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Washington Post Live","authorlink":""},"src":"https:\/\/www.podtrac.com\/pts\/redirect.mp3\/podcast.washpostpodcasts.com\/washpost-production\/5a21a2d9e4b0f49da26f53cf\/20210304\/60415640c9e77c000813951a\/t_1614894857416_name_t_1614894587324_name_gorsky_pod.mp3?awCollectionId=5a21a2d9e4b0f49da26f53cf&awEp","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202211\/7d3de9-8969-8703-aa25d7_800.jpg"},"title":"The Path Forward: Vaccines with Johnson a Johnson CEO Alex Gorsky","link":"javascript:;","id":"item-332295"}]